Skip to main content

Table 1 Baseline characteristics of inflammatory bowel disease (ulcerative colitis and Crohn’s disease) patients and controls

From: Genetic polymorphism of HLA-G gene (G*01:03, G*01:04, and G*01:05N) in Iraqi patients with inflammatory bowel disease (ulcerative colitis and Crohn’s disease)

Characteristics

UC (N = 50)

CD (N = 50)

HC (N = 100)

p

Mean age ± SD; year

31.5 ± 10.1

30.5 ± 9.7

31.2 ± 9.8

0.864

Gender; N (%)

Male

28 (56.0)

28 (56.0)

57 (57.0)

0.990

Female

22 (44.0)

22 (44.0)

43 (43.0)

 

Current cigarette-smokers; N (%)

 

40 (80.0)

35 (70.0)

39 (39.0%)

< 0.001

Disease duration; N (%); year

≤ 3

20 (40.0)

25 (50.0)

NA

0.314

 

> 3

30 (60.0)

25 (50.0)

NA

 

Positive family history; N (%)

 

7 (14.0)

8 (16.0)

NA

0.779

Disease extension; N (%)

Ulcerative proctitis

20 (40)

NA

NA

 

Left-sided colitis

15 (30)

NA

NA

 

Extensive colitis

15 (30)

NA

NA

 

Ileocecal colitis

NA

43 (86.0)

NA

 

Ileocecal + colon

NA

7 (14.0)

NA

 

Symptoms; N (%)

Abdominal/colon pain

35 (70.0)

31 (62.0)

NA

0.527

Diarrhea

30 (60.0)

26 (52.0)

NA

0.546

Fever

25 (50.0)

24 (48.0)

NA

1.000

Extra-intestinal manifestations; N (%)

Aphthous ulcer

11 (22.0)

13 (26.0)

NA

0.308

Arthralgia

32 (62.0)

40 (80.0)

NA

0.118

Skin rash

7 (14.0)

3 (6.0)

NA

0.318

Appendectomy

7 (14.0)

6 (12.0)

NA

1.000

Bowel stricture

2 (4.0)

5 (10.0)

NA

0.436

Colostomy

8 (16.0)

3 (6.0)

NA

0.200

Fistula

10 (20.0)

6 (12.0)

NA

0.414

Hemorrhoid

4 (8.0)

5 (10.0)

NA

1.000

Laboratory findings; mean ± SD

Hb (mg/dL)

11.0 ± 3.0

10.5 ± 3.5

NA

0.682

WBC (× 109/L)

8.1 ± 3.6

7.7 ± 3.1

NA

0.783

ESR (mm/h)

54.3 ± 22.5

58.8 ± 42.4

NA

0.876

sHLA-G (ng/mL)a

180.5 ± 27.1

168.9 ± 26.3

126.8 ± 15.1

< 0.001

  1. UC ulcerative colitis, CD Crohn’s disease, HC healthy controls, Hb hemoglobin, WBC white blood cell, ESR erythrocyte sedimentation rate, SD standard deviation, p LSD (least significant difference) or two-tailed Fisher’s exact probability (significant p value is indicated in bold), NA not applicable
  2. aThe mean was based on 30 samples of each group (UC, CD, or HC)